AbbVie Wants MedImmune's Humira Patent Invalidated
AbbVie Inc. filed a suit Friday in Maryland federal court seeking to invalidate a patent held by MedImmune LLC covering AbbVie's blockbuster arthritis drug Humira, saying the patent is invalid under...To view the full article, register now.
Already a subscriber? Click here to view full article